AI software scans the images for lung nodules, emphysema, the quantitative degree of emphysema, interstitial lung disease and coronary artery calcification. These findings are then reviewed by ...

Multiple sclerosis (MS) and systemic lupus erythematosus (lupus) are both serious diseases that result from a failure of the body’s immune system to function properly. There’s some debate ...

Methods We collected sera from patients with SLE (n=64), patients with other autoimmune diseases (n=31) and healthy controls (n=35), and assayed them using a cell-based reporter system that enables ...

Systemic lupus erythematosus (SLE) is a heterogeneous multisystem inflammatory disease with wide variability in clinical manifestations. Natural arising CD4+ regulatory T cells (Tregs) play a critical ...

In this study, for the first time, we show that IFN-α assessed by digital ELISA and IFN-I gene score perform equally for identifying the association of IFN-I with SLE disease activity and clinical ...

16 This number might not accurately reflect the true prevalence of nonischemic DCM, because a significant proportion of these patients will have HF caused by hypertension or valvular heart disease.

Edema was associated with female sex, comorbid cardiac disease, and pramipexole. Development of hallucinations was associated with older age, worse Mini-Mental State Exam scores, and burden of ...

CAD secondary to SLE most often presents at the onset of lupus, but it occasionally develops within the first 5 years. Although rare, secondary cold agglutinin disease (CAD), a type of autoimmune ...

In the 5/6 nephrectomy rat model of chronic kidney disease in which diabetes does not feature, SGLT2 inhibition with empagliflozin ameliorated glomerular hypertrophy, glomerulosclerosis and ...

Being diagnosed with interstitial cystitis while simultaneously searching for answers about a mysterious autoimmune/inflammatory disease made 2024 the hardest year of my life." A post shared by ...

These risks include gastrointestinal disorders, low blood pressure, nephrolithiasis (kidney stone disease), interstitial nephritis, and drug-induced pancreatitis. Perhaps surprisingly, given the ...

An investigator-initiated Phase 1/2 trial of CNTY-101, an investigational therapy, has been announced for the treatment of B-cell mediated autoimmune diseases, including systemic lupus erythematosus ...